Example: Heart Attack
Clinical Trials on Tyrosinemia Type 1
Total 1 results
-
NCT03284658Active, not recruitingConditions: Tyrosinosis, Hepatorenal Tyrosinemia, Fumarylacetoacetase Deficiency, Fah Deficiency, Metabolic Disorders
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Choroideremia
- Chronic Thromboembolic Pulmonary Hypertension
- Juvenile Polyposis Syndrome
- Keratoacanthoma
- Mitochondrial Complex II Deficiency
- Myelomeningocele
- Pancreatic Neuroendocrine Tumor
- Rhabdomyoma
- Sex Cord-Gonadal Stromal Tumors
- Staphylococcal Skin Infections
- Translocation, Genetic
- Urethral Diseases
- Waldenstrom Macroglobulinemia
- View Full List
Sponsors and Collaborators
- Aeon Astron Europe B.V.
- Altitude Physiology Expeditions
- Cougar Biotechnology, Inc.
- North Shore Long Island Jewish Health System
- Rapid City Regional Hospital, Inc
- Respivert Ltd
- Santa Casa de Passos
- St. Luke's Hospital, Pennsylvania
- Symyoo
- Ultrasound Laboratory at Malmoe University Hospital, Sweden
- Unfallkrankenhaus Berlin
- ViroStatics srl
- pSiVida Limited
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations